Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
Zhejiang Jolly Pharmaceutical: Half-year report for the year 2024.
Jul 30 00:00
Zhejiang Jolly Pharmaceutical: Summary of Half-Year Report in 2024.
Zhejiang Jolly Pharmaceutical: 2024 Interim Performance Forecast
Jul 10 18:36
Zolite Pharmaceuticals: 2023 Annual Report Summary
Apr 19 00:00
Read more
Updated: Aug 28, 2024
Strong Buy
Buy
Hold
Underperform
Sell
No Data